Alirocumab and Evolocumab are:
High-Yield Explanation
PCSK - 9 expressed over many tissues which inhibits metabolism of LDL - receptors. Drugs like Alirocumab & Evolocumab inhibit PCSK - 9 and increased LDL - receptor turnover. Thus they decrease the levels of LDL.